CHEMED CORP 10-Q Summary: Quarter Ended March 31, 1994
Business Context and Reporting Period
This Form 10-Q covers the three-month period ended March 31, 1994. Chemed Corporation operates through four primary segments: National Sanitary Supply, Roto-Rooter, Veratex, and Patient Care (acquired January 1, 1994). The company reported 9,844,553 shares of common stock outstanding as of April 29, 1994.
Key Financial Metrics
| Metric | Q1 1994 | Q1 1993 |
|---|---|---|
| Total Sales and Service Revenues | $152,069,000 | $120,519,000 |
| Income from Operations | $5,670,000 | $3,892,000 |
| Net Income | $5,677,000 | $5,729,000 |
| Earnings Per Share (Diluted) | $0.58 | $0.59 |
| Operating Margin | 4.7% | 4.6% |
| Cash and Cash Equivalents | $12,833,000 | $27,719,000 (End of Q1 1993) |
| Net Cash Provided by Operating Activities | $7,106,000 | $6,827,000 |
| Long-Term Debt | $110,255,000 | $98,059,000 (Dec 31, 1993) |
| Unused Lines of Credit | $34,250,000 | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated revenues increased 26% year-over-year, driven primarily by the acquisition of Patient Care Inc. and Encore Service Systems Inc. Organic growth (excluding acquisitions) was 6%.
- Segment Performance: Roto-Rooter revenues surged 51% due to the Encore acquisition. National Sanitary Supply grew 3% despite earthquake disruptions in Southern California. Veratex grew 2% despite severe winter weather impacts.
- Profitability: While operating income increased 46%, Net Income decreased slightly ($52,000) due to a higher effective tax rate (40.7% vs. 31.2%) and the absence of a one-time accounting gain recorded in Q1 1993.
- Investment Gains: Other income rose significantly due to a $4.8 million pre-tax gain on the sale of investments, compared to $2.6 million in the prior year.
- Balance Sheet: Total assets increased to $475.3 million, largely due to goodwill from acquisitions and the revaluation of investments under SFAS 115.
Guidance, Outlook, and Risks
- Acquisition Contingencies: The purchase of Patient Care includes potential additional cash payments of up to $10.4 million contingent on earnings performance through December 31, 1995.
- Regulatory Matters: An application for the transfer of ownership of one Patient Care region is pending state regulatory approval, expected in 1994.
- Accounting Changes: The company adopted SFAS 115 effective January 1, 1994, classifying securities as "trading" or "available for sale," resulting in a $12.9 million increase to stockholders' equity.
- Debt Structure: Interest expense declined due to the replacement of high-interest Series A Senior Notes with lower-rate borrowings (approx. 5%). A new $10 million term loan was secured in March 1994.
- Operational Risks: Management noted weather-related impacts on Veratex and earthquake disruptions affecting National Sanitary Supply operations.
Investor Verification Checklist
- Verify the realization of contingent payments for the Patient Care acquisition based on future earnings.
- Monitor the integration of Encore Service Systems into Roto-Rooter to assess margin improvement potential.
- Confirm the approval status of the Patient Care regional ownership transfer with state regulators.
- Review the sustainability of the 40.7% effective tax rate compared to historical norms.
- Assess the impact of the SFAS 115 adoption on future unrealized gains/losses reported in equity.